æã交尾ã®å¾ã«ã¡ã¹ã®äº¤å°¾å¨ãå£ãã¦ãã¾ãã¯ã¢ãçºè¦ã¨ããè¨äºããã·ã§ãã«ã¸ãªã°ã©ãã£ãã¯ã®ãµã¤ãã«åºã¦ããã®ã«æ°ãã¤ãã¦ã®ãããããã®æ¥è¨ã§ããã³ãã³æ¸ãã¦ãã¦ããäºã ããç§ãã®ã³ã¡ããã´ãã°ã¢ã§äº¤å°¾å¾ã«ã¡ã¹ã®äº¤å°¾å¨ãç ´å£ãããããã«ããã¡ã¹ã®å交尾è½åã失ãããäºãçºè¦ãã¦ããããã ãªã種ã¯éãã©ããå ¨ãåãå 容ã®ç 究ã ãããã¯ä¸çã§åãã¦ã®çºè¦ãªã®ã§ãç§çã«ã¯è奮ãã¦1å¹´åããããå®é¨ãã¦ãã¦ããã¨ãããå ¨ãåãç 究ãä»æããåºãã¨ããäºã¯ãçºè¦è ã¯ç§ãããªãäºã«ãªã£ã¦ãã¾ãããã§ãã¨ã¦ãè¾ããå®éã¯ç¬ç«ã«äºã¤ã®ç 究ãè¡ããã¦ããããã ããç§å¦ã®ä¸çã§ã¯è«æã®åºçãå ¨ã¦ãªããã§ãããããç§ãè¦ã¤ãã¦ãããã£ã¦è¨ã£ã¦ãä»æ¹ãªãããããããããããäºã¯çã馬ã®ç®ãæãæå 端ã®çå½ç§å¦åéã§èµ·ãããã®ã§ãã¾ããã®ã©ããªåç©è¡åå¦åéã«æ®ããç§ããããªçµé¨ããããªãã¦æããªãã£ãããããããæ¬
2012å¹´2æ4æ¥ The Economist éªå´©ã¯ããã£ãä¸ç²ã®å°ç³ã«ãã£ã¦å¼ãèµ·ãããããã¨ãããã 1æ21æ¥ãã±ã³ããªãã¸å¤§å¦ã®æ°å¦è Timothy Gowers ãã é·å¹´ã«æ¸¡ã£ã¦ã¨ã«ã¼ãã¢ç¤¾ã®è«æèªããã¤ã³ãããã¦ããçç±ã«ã¤ãã¦ãããã°ã«æ¸ããã ãªã©ã³ãã«æ¬ç¤¾ãç½®ãå社ã¯ãä¸æµèª Cell ã Lancet ãã¯ããã¨ããå®æåè¡èªã2000èªææãã¦ããã ãã¼ãã«è³ã®æ°å¦çã¨ããããã£ã¼ã«ãºè³ãåè³ãã Gowers å士ã¯ããã®ç¶æ³ãæã¾ãããªãã¨èãã ä»åã®ããã°è¨äºãä»ã®å¦è ããã¤ã³ããã«åå ãããã£ããã«ãªãã°ãã¨æãã§ããã å®éããããèµ·ãã£ãã Gowers ã®ããã°ã«æåããã¦ãæ°å¦è Tyler Neylon ããªã³ã©ã¤ã³ç½²åãµã¤ããè¨ç½®ãã ãã®ãµã¤ããéãã¦ç 究è 2700人以ä¸ï¼è¨³æ³¨ï¼æ¥æ¬èªè¨³å·çæç¹ã§ã¯5300人以ä¸ï¼ãç½²åãã èªåã®ç 究
ãã2æ¥ã°ãã綺éºäºã°ããæ¸ãã¦ãã¾ããããããããæ¬é¡ã çå¦ãã¦ã³ã£ããããã®ã¯ã欧米人ã¯å¤§æµ9æ5æã§å¸°ããã¨ã§ãããä»äºãç«ã¦è¾¼ãã§ããã¨ãã¯å¤é ãã¾ã§æ®ããã¨ããããã1é±éãç¶ãã°è¯ãæ¹ã§ããããå¹´ã«1ï¼2åç¨åº¦ã ä¸æ¹ãæ¥æ¬äººç 究è ã¯æ¥æ¬ã§ãæµ·å¤ã§ãã家æãããªããã°ãæä¸çªã«ã¯ããã¦å¤ä¸ã®11æ12æã¾ã§ãããªãã¦ã®ã¯ããããå æ¯ãé£äºã¨å¯ã¦ããæé以å¤å ¨é¨ç 究ãã¦ããã¨ãã人ã¯çµæ§å¤ãã ã§ãæ¥æ¬ããNature, Science, Cellãã¢ã¡ãªã«ã»ã©åºãªãã®ã¯ä¸æè°ã§ã¯ãªãã§ããããï¼ãããããã®æ°ã¯æ¸ãå¾åããããããã§ãã ãã®çç±ã¯ããã¤ããã£ã¦ãæ¥æ¬ã¯ãããªã¢ã«ä½ãããå§ããã®ã«å¯¾ãã¦ãæµ·å¤ã®ããã¯ã©ãã¯å¤§æµä½æã®ã©ããããããªã¢ã«ãè²°ã£ã¦ãä¸çªæ¥½ã§ä¸çªå¤§ããªçµæãå¾ãããæå¾ã®å®é¨ã ããããªãã¦ã®ã¯è¯ããã話ããã¡ãããå ¨ãæ°ããç³»ãä¸äººã§ç«ã¡ä¸ããçè ã
ä¸çã®ã©ãã§ãã»ãã®æ°ç§ã§æ å ±ãæã«å ¥ãããã¨ãåºæ¥ãããã«ãªããå°å·åªä½ã®æ å ±ã¯åºãé端ã«æ代é ãã¨ãªãã«çããä»ãå¦è¡ç 究ã®åéã§ãªãå¦ä¼èªããã¾ã ã«éè¦ãªä½ç½®ãå ãã¦ããã®ã ããã? å¦ä¼èªã§ã¯è«æãæ稿ããã¦ããçºè¡ãããã¾ã§1ã2å¹´ããããã¨ãå¤ããæ å ±ã¯æã«å ¥ãæãã¨ã¯è¨ãããã(ãããã¯æã«å ¥ããããã«é«ãéé¡ãæãå¿ è¦ããã)ããããåå ã§æè¡é²æ©ã妨ãããããããªãã®ã ããã? æ»èªä»ãã®çºè¡¨ã®å ´ã¯ä»ã«ãããããªã®ã«ä½æ ããã§ãå¦ä¼èªãªã®ã ãã? å¦ä¼èªã¯ä»ã社ä¼ã«ä½ãããããã¦ããã®ã ãã? ãã åã«ææãã¡ã®çç£æ§ãè©ä¾¡ããããã®ãã®ã«éããªãã®ã ããã? å®éãç¾å¨ã®å¦ä¼èªã®å½±é¿åãä½ç½®ã¥ãã¨ã¯ã©ã®ãããªãã®ãªã®ã ããã? æã¨ä»ã§ã¯å¤åããããã¦ããã®ã ããã? å¦è¡çã«èº«ãç½®ã/.Jerã®çæ§ã®è¦è§£ããã²ãèããé¡ãããã
ç®æ¬¡ ããã¨ãã è«æãæ¸ãã¨ãã®ä½æ¥ã«é¢ããã㨠è¾æ¸ã¯ã©ããªãµãã«ä½¿ãã¨ããã ã¹ãã«ãã§ã㯠è«æã®è¡¨è¨æ³ã»å½¢å¼ã«é¢ããã㨠ã³ã³ãï¼ããªãªãï¼ã»ãã³ãã³ åèªã®é æåã«ããç¥èªã¨ãã®è¡¨è¨ è«æã®è¡¨é¡ï¼ã»ã¯ã·ã§ã³ã®ã¿ã¤ãã«ï¼å³ã®ãã£ãã·ã§ã³ãªã©ã«ããã大æå㨠å°æå ãã©ã³ãã«ã¤ãã¦ã®æ³¨æ "a MIMD machine" 㨠"an MIMD machine" è«æã®æä½ã«é¢ããã㨠è±èªè«æã«ãããä¸äººç§°è¤æ° "we" æé ã® "And", "But" æä¸ã® "and", "but" åè©ã®åæ°å½¢ã¨è¤æ°å½¢ï¼"a"ã¨"the" 主é¨ã¨è¿°é¨ã®é·ãã®ãã©ã³ã¹ ãã¾ã è«æã«ããããªãè¡¨ç¾ ç¥ã£ã¦ããã¨ä¾¿å©ãªè¡¨ç¾ ããã¨ãã ãã®ææ¸ã¯ï¼è±èªã§è«æãæ¸ãå ´åã«æä½ãã®ä»ã§æä½é注æãã¦æ¬²ãããªã ã¨ç§ãæããã¨ãæ´çãããã®ã§ããï¼ããããæ£ããè±èªè«æã ãã¨è¨ã£ã¦ããããã§ã¯ãªãã¦
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}